These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


346 related items for PubMed ID: 9222700

  • 1. DNA ploidy, proliferative index and EGF-R status in 130 cases of resected gastric cancer--a multivariate analysis.
    Santoro E, Carboni M, Catarci M, Carlini M, Carboni F, Zupi G, Vecchione A, D'Agnano I, Giannarelli D, Santoro R, Garofalo A.
    Hepatogastroenterology; 1997; 44(15):826-37. PubMed ID: 9222700
    [Abstract] [Full Text] [Related]

  • 2. DNA ploidy, proliferative index, and epidermal growth factor receptor: expression and prognosis in patients with gastric cancers.
    D'Agnano I, D'Angelo C, Savarese A, Carlini M, Garofalo A, Bottari L, Santoro E, Giannarelli D, Vecchione A, Zupi G.
    Lab Invest; 1995 Apr; 72(4):432-8. PubMed ID: 7723282
    [Abstract] [Full Text] [Related]

  • 3. DNA content by flow cytometry in gastric carcinoma: pathology, ploidy and prognosis.
    Esteban F, de Vega DS, Garcia R, Rodriguez R, Manzanares J, Almeida A, Tamames S.
    Hepatogastroenterology; 1999 Apr; 46(27):2039-43. PubMed ID: 10430394
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Prognostic impact of DNA ploidy pattern, S-phase fraction (SPF), and proliferating cell nuclear antigen (PCNA) in patients with primary gastric lymphoma.
    Belessi CJ, Parasi AS, Manioudaki HS, Laoutaris NP, Legakis NC, Peros GT, Androulakis GA.
    J Surg Oncol; 2003 Apr; 82(4):247-55. PubMed ID: 12672009
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Mutated p53 protein expression and proliferative activity in advanced gastric cancer.
    Ikeguchi M, Saito H, Kondo A, Tsujitani S, Maeta M, Kaibara N.
    Hepatogastroenterology; 1999 Apr; 46(28):2648-53. PubMed ID: 10522058
    [Abstract] [Full Text] [Related]

  • 8. Prognostic significance of DNA ploidy and proliferation in 309 colorectal carcinomas as determined by two-color multiparametric DNA flow cytometry.
    Zarbo RJ, Nakhleh RE, Brown RD, Kubus JJ, Ma CK, Mackowiak P.
    Cancer; 1997 Jun 01; 79(11):2073-86. PubMed ID: 9179053
    [Abstract] [Full Text] [Related]

  • 9. Adenocarcinoma in the middle third of the stomach--an evaluation for the prognostic significance of clinicopathological features.
    Sheen-Chen SM, Chou CW, Chen MC, Chen FC, Chen YS, Chen JJ.
    Hepatogastroenterology; 1997 Jun 01; 44(17):1488-94. PubMed ID: 9356878
    [Abstract] [Full Text] [Related]

  • 10. Flow cytometric DNA analysis of gastric cancer that is invading the muscularis propria.
    Mizunuma H, Tsuchiya A, Ando Y, Kikuchi Y, Abe R.
    Eur J Surg; 1996 Nov 01; 162(11):889-94. PubMed ID: 8956958
    [Abstract] [Full Text] [Related]

  • 11. [Quantitative estimation of malignancy of gastric cancer by DNA ploidy and proliferative activities].
    Yonemura Y, Miyazaki I.
    Rinsho Byori; 1990 Sep 01; 38(9):1053-8. PubMed ID: 2232266
    [Abstract] [Full Text] [Related]

  • 12. Ki-67, ploidy and S-phase fraction as prognostic factors in gastric cancer.
    Victorzon M, Roberts PJ, Haglund C, von Boguslawsky K, Nordling S.
    Anticancer Res; 1997 Sep 01; 17(4B):2923-6. PubMed ID: 9329565
    [Abstract] [Full Text] [Related]

  • 13. DNA ploidy as a prognostic factor for patients with an adenocarcinoma in Barrett's esophagus.
    Menke-Pluymers MB, Hop WC, Mulder AH, Tilanus HW.
    Hepatogastroenterology; 1995 Sep 01; 42(6):786-8. PubMed ID: 8847023
    [Abstract] [Full Text] [Related]

  • 14. Is tumor size a prognostic indicator for gastric carcinoma?
    Yokota T, Ishiyama S, Saito T, Teshima S, Yamada Y, Iwamoto K, Takahashi M, Murata K, Yamauchi H.
    Anticancer Res; 2002 Sep 01; 22(6B):3673-7. PubMed ID: 12552975
    [Abstract] [Full Text] [Related]

  • 15. Morphometry of gastric carcinoma: its association with patient survival, tumour stage, and DNA ploidy.
    Hamilton PW, Wyatt JI, Quirke P, Watt PC, Arthur K, Ward DC, Johnston D.
    J Pathol; 1992 Oct 01; 168(2):201-8. PubMed ID: 1460537
    [Abstract] [Full Text] [Related]

  • 16. Analysis of survival factors in patients with advanced-stage gastric adenocarcinoma.
    Alici S, Kaya S, Izmirli M, Tuncer I, Doğan E, Ozbek H, Sayarlioglu H.
    Med Sci Monit; 2006 May 01; 12(5):CR221-9. PubMed ID: 16641880
    [Abstract] [Full Text] [Related]

  • 17. Prognostic value of Ki-67 expression, ploidy and S-phase fraction in patients with pancreatic cancer.
    Lundin J, Nordling S, von Boguslawsky K, Roberts PJ, Haglund C.
    Anticancer Res; 1995 May 01; 15(6B):2659-68. PubMed ID: 8669843
    [Abstract] [Full Text] [Related]

  • 18. Significant prognostic factors in patients with early gastric cancer.
    Yokota T, Kunii Y, Teshima S, Yamada Y, Saito T, Takahashi M, Kikuchi S, Yamauchi H.
    Int Surg; 2000 May 01; 85(4):286-90. PubMed ID: 11589593
    [Abstract] [Full Text] [Related]

  • 19. Alteration of DNA ploidy status and cell proliferation induced by preoperative radiotherapy is a prognostic factor in rectal cancer.
    Lammering G, Taher MM, Gruenagel HH, Borchard F, Porschen R.
    Clin Cancer Res; 2000 Aug 01; 6(8):3215-21. PubMed ID: 10955806
    [Abstract] [Full Text] [Related]

  • 20. DNA ploidy is a major prognostic factor in advanced gastric carcinoma--univariate and multivariate analysis.
    Haraguchi M, Watanabe A, Moriguchi S, Korenaga D, Maehara Y, Okamura T, Sugimachi K.
    Surgery; 1991 Nov 01; 110(5):814-9. PubMed ID: 1948649
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.